Literature DB >> 1847249

Adrenal suppression and steroid supplementation in renal transplant recipients.

J S Bromberg1, E J Alfrey, C F Barker, K D Chavin, D C Dafoe, T Holland, A Naji, L J Perloff, L A Zellers, R A Grossman.   

Abstract

The use of increased dosages of glucocorticoids during periods of physiologic stress in allograft recipients represents a clinical dilemma in that the short-term exogenous therapy required may significantly impair wound healing and immunocompetence. To investigate whether "stress steroids" are actually necessary, a prospective study was conducted in 40 renal allograft recipients admitted with significant physiologic stress. Stress categories included sepsis, metabolic abnormalities, and surgery. These patients received only their baseline prednisone immunosuppression (5-10 mg/day) and no supraphysiologic or stress doses of glucocorticoids. The clinical course of the patients revealed no evidence of adrenal insufficiency. There was no mortality, increase in hospital stay, or eosinophilia. Five episodes of hyponatremia and seven instances of hypotension were attributed to primary disease processes and responded promptly to specific treatment without steroid supplementation. Biochemical evaluation during stress revealed suppression of ACTH levels in 74.5% of episodes, elevation of urinary free cortisol levels in 79.1% of episodes, and elevation of isolated serum cortisol levels in 55.9% of episodes. This suggested that these patients had physiologically adequate adrenal function. The cosyntropin stimulation test overestimated the incidence and degree of clinically significant adrenal dysfunction (63% of patients) and was not a useful indication of a requirement for additional glucocorticoids. We conclude that functional adrenal suppression is uncommon in renal allograft recipients receiving baseline prednisone immunosuppression (5-10 mg/day) and that the demands of physiologic stress are met by a combination of endogenous adrenal function plus exogenous, baseline, immunosuppressive doses of glucocorticoids. Supra-physiologic or high doses of so-called "stress steroids" are not required. The cosyntropin stimulation test has significant clinical limitations and did not serve to alter clinical care.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847249     DOI: 10.1097/00007890-199102000-00023

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  12 in total

1.  Perioperative management of patients with connective tissue disease.

Authors:  Susan M Goodman; Mark P Figgie; C Ronald Mackenzie
Journal:  HSS J       Date:  2010-08-17

Review 2.  Inflammatory bowel disease: perioperative pharmacological considerations.

Authors:  Ajay Kumar; Moises Auron; Ashish Aneja; Franziska Mohr; Alok Jain; Bo Shen
Journal:  Mayo Clin Proc       Date:  2011-08       Impact factor: 7.616

Review 3.  Adrenal crises: perspectives and research directions.

Authors:  R Louise Rushworth; David J Torpy; Henrik Falhammar
Journal:  Endocrine       Date:  2016-12-19       Impact factor: 3.633

Review 4.  Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem.

Authors:  M Salem; R E Tainsh; J Bromberg; D L Loriaux; B Chernow
Journal:  Ann Surg       Date:  1994-04       Impact factor: 12.969

5.  Laparoscopic cholecystectomy in pancreas transplant recipients.

Authors:  D B Adams; J S Bromberg
Journal:  Surg Endosc       Date:  1994-08       Impact factor: 4.584

6.  Perioperative management of medications used in the treatment of rheumatoid arthritis.

Authors:  Carla R Scanzello; Mark P Figgie; Bryan J Nestor; Susan M Goodman
Journal:  HSS J       Date:  2006-09

Review 7.  Steroids in kidney transplant patients.

Authors:  Robert W Steiner; Linda Awdishu
Journal:  Semin Immunopathol       Date:  2011-02-18       Impact factor: 9.623

8.  Systemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review.

Authors:  Rebecca M Joseph; Ann Louise Hunter; David W Ray; William G Dixon
Journal:  Semin Arthritis Rheum       Date:  2016-03-09       Impact factor: 5.532

9.  Hyponatremia in kidney transplant patients: its pathophysiologic mechanisms.

Authors:  Carlos G Musso; Alejandrina Castañeda; María Giordani; Cesar Mombelli; Silvia Groppa; Nora Imperiali; Guillermo Rosa Diez
Journal:  Clin Kidney J       Date:  2018-03-16

Review 10.  Perioperative corticosteroid administration: a systematic review and descriptive analysis.

Authors:  C Groleau; S N Morin; L Vautour; A Amar-Zifkin; A Bessissow
Journal:  Perioper Med (Lond)       Date:  2018-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.